New York Life Investment Management LLC Has $358,000 Position in Veradigm Inc. (NASDAQ:MDRX)

New York Life Investment Management LLC trimmed its holdings in shares of Veradigm Inc. (NASDAQ:MDRXFree Report) by 13.6% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 27,283 shares of the software maker’s stock after selling 4,298 shares during the quarter. New York Life Investment Management LLC’s holdings in Veradigm were worth $358,000 as of its most recent filing with the SEC.

A number of other hedge funds have also modified their holdings of the company. New York State Common Retirement Fund grew its position in shares of Veradigm by 29.9% in the 3rd quarter. New York State Common Retirement Fund now owns 75,030 shares of the software maker’s stock valued at $986,000 after acquiring an additional 17,287 shares during the period. Illinois Municipal Retirement Fund bought a new position in shares of Veradigm during the third quarter worth about $825,000. Orion Portfolio Solutions LLC bought a new position in shares of Veradigm in the 3rd quarter worth about $313,000. Teacher Retirement System of Texas lifted its holdings in shares of Veradigm by 3.7% in the 3rd quarter. Teacher Retirement System of Texas now owns 73,490 shares of the software maker’s stock worth $966,000 after purchasing an additional 2,639 shares in the last quarter. Finally, Assetmark Inc. increased its holdings in Veradigm by 15.5% during the 3rd quarter. Assetmark Inc. now owns 62,008 shares of the software maker’s stock worth $815,000 after purchasing an additional 8,310 shares in the last quarter.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the stock. StockNews.com assumed coverage on shares of Veradigm in a research report on Sunday. They issued a “hold” rating for the company. Stephens reaffirmed an “equal weight” rating and set a $13.00 price target on shares of Veradigm in a research report on Tuesday, November 14th. Barclays initiated coverage on Veradigm in a report on Wednesday, January 3rd. They issued an “equal weight” rating and a $11.00 price target on the stock. Finally, Royal Bank of Canada dropped their target price on Veradigm from $22.00 to $11.00 and set an “outperform” rating for the company in a report on Friday, January 19th. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $14.00.

Read Our Latest Research Report on MDRX

Veradigm Trading Up 0.5 %

NASDAQ:MDRX opened at $8.54 on Monday. Veradigm Inc. has a 1-year low of $8.23 and a 1-year high of $17.84. The company’s fifty day moving average price is $9.93 and its 200-day moving average price is $11.97.

Veradigm Company Profile

(Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Stories

Institutional Ownership by Quarter for Veradigm (NASDAQ:MDRX)

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.